Unique ID issued by UMIN | UMIN000046257 |
---|---|
Receipt number | R000052731 |
Scientific Title | Effects of mobile health usage in Japanese patients with diabetes receiving insulin/GLP-1 receptor agonist: Randomized controlled trial (mHealth-DM-insulin/GLP-1RA) |
Date of disclosure of the study information | 2021/12/02 |
Last modified on | 2022/09/16 06:49:00 |
Effects of mobile health usage in Japanese patients diabetes receiving insulin/GLP-1 receptor agonist: Randomized controlled trial (mHealth-DM-insulin/GLP-1RA)
Effects of mHealth in Japanese DM on insulin/GLP-1 receptor agonist (mHealth-insulin/GLP-1RA)
Effects of mobile health usage in Japanese patients with diabetes receiving insulin/GLP-1 receptor agonist: Randomized controlled trial (mHealth-DM-insulin/GLP-1RA)
Effects of mHealth in Japanese DM on insulin/GLP-1 receptor agonist (mHealth-DM-insulin/GLP-1RA)
Japan |
diabetes
Endocrinology and Metabolism |
Others
NO
To assess the impact of use of mobile health on HbA1c, weight management and QOL for diabetic patients.
Safety,Efficacy
Changes in HbA1c after 6 months use of mHealth
Changes in weight, HDL-c, LDL-c, TG, self-injection adherence, DTR-QOL, SDSCA, FFQ, App usage continuation rate and hypoglycemia frequency after usage of mHealth for 6 months
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Educational,Counseling,Training
Behavior,custom |
Incorporate mHealth into the usual treatment for 6 months
Perform regular medical care for 6 months
20 | years-old | <= |
75 | years-old | > |
Male and Female
The patients who meets all conditions follows:
1) Diabetic patients using SMBG over 3 months who have used self-injecting insulin, GLP-1 receptor agonists, or both
2) Smarat phone users over 6 months
3) Patients who the attending physician has determined to be able to answer various questionnaires
4) Age 20 or over, under 75
5) HbA1c 7.0% or over, under 11.0% (under 65 years old), 7.5% or over (Age 65 or over, under 75 years old)
6) BMI 18 or more, less than 35
The patients who meets any of the conditions follows:
1) Patients suspected of having dementia or mental disease
2) Patients with serious liver or kidney disease
3) Hb under 10 g/dL
4) Patients who undergo surgical resection or chemotherapy for malignant neoplasms or who have performed it within the past 5 years
5 Patients who use steroids as therapeutic agents (excluding inhalation or intment)
6) Patients who are judged to be inappropriate for this research
180
1st name | Daisuke |
Middle name | |
Last name | Yabe |
Gifu University Hospital
Division of Diabetes, Endocrinology and Metabolism, Division of Rheumatology and Clinical Immunology
501-1194
1-1 Yanagido, Gifu 501-1194, Japan
058-230-6377
ydaisuke-kyoto@umin.ac.jp
1st name | Makie |
Middle name | |
Last name | Honda |
Gifu University Hospital
Division of Diabetes, Endocrinology and Metabolism, Division of Rheumatology and Clinical Immunology
501-1194
1-1 Yanagido, Gifu 501-1194, Japan
058-230-6377
komanyan66@gmail.com
Gifu University Hospital
H2.Inc
Profit organization
Central ethics committee of Gifu University
/1-1 Yanagido, Gifu 501-1194, Japan
+81582306000
rinri@gifu-u.ac.jp
NO
松波総合病院
岐阜県総合医療センター
岐阜市民病院
2021 | Year | 12 | Month | 02 | Day |
Unpublished
Open public recruiting
2021 | Year | 06 | Month | 15 | Day |
2021 | Year | 07 | Month | 30 | Day |
2022 | Year | 01 | Month | 01 | Day |
2024 | Year | 05 | Month | 31 | Day |
2021 | Year | 12 | Month | 02 | Day |
2022 | Year | 09 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052731
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |